Cotinine ameliorates memory and learning impairment in senescent mice

Area of Science:

• Neuroscience
• Pharmacology
• Aging Research

Background:

• Aging is associated with cognitive decline, including memory and learning impairments.
• These age-related deficits are linked to changes in hippocampal pathways.
• Understanding interventions to mitigate cognitive decline is crucial.

Purpose of the Study:

• To investigate the effects of cotinine on age-induced memory and learning deficits in mice.
• To explore the role of alpha7 nicotinic acetylcholine receptors (α7 nAChRs) in cotinine's effects.
• To analyze downstream molecular pathways affected by cotinine in the hippocampus.

Main Methods:

• Aged and young mice were treated with cotinine and/or methyllycaconitine (MLA), an α7 nAChRs antagonist.
• Behavioral tests, including the Morris water maze (MWM) and novel object recognition (NOR), assessed cognitive function.
• Hippocampal levels of oxidative stress markers, inflammatory cytokines, synaptic plasticity proteins, and neurotrophic factors were measured.

Main Results:

• Cotinine treatment significantly improved learning and memory in aged mice.
• Cotinine increased antioxidant capacity, synaptic plasticity markers, and neurotrophic factors while reducing oxidative stress and neuroinflammation.
• Blocking α7 nAChRs with MLA reversed the beneficial effects of cotinine.

Conclusions:

• Cotinine ameliorates age-related memory and learning impairments in mice.
• These effects are mediated through the modulation of α7 nAChRs and downstream signaling pathways in the hippocampus.
• Cotinine shows potential as a therapeutic agent for cognitive aging.